Form 424B5 Celldex Therapeutics Inc For: 2 April
#Celldex Therapeutics #Form 424B5 #SEC filing #prospectus #securities offering #biotech #regulatory disclosure
📌 Key Takeaways
- Celldex Therapeutics Inc. filed a Form 424B5 with the SEC on April 2.
- Form 424B5 is a prospectus supplement for securities offerings.
- The filing provides updated details on a specific securities offering.
- It is a routine regulatory disclosure for public companies.
🏷️ Themes
Regulatory Filing, Biotechnology Finance
Entity Intersection Graph
No entity connections available yet for this article.